Key result
Exposure to clotting factor VIII lot no. 1950177 was associated with an outbreak of hepatitis A among haemophilia patients.
Why the study?
Is exposure to specific lots of blood clotting factors associated with hepatitis A virus infection in haemophilia patients?
Case-Control (n=123)
Is exposure to specific lots of blood clotting factors associated with hepatitis A virus infection in haemophilia patients?
The study identified a specific lot of clotting factor VIII as the source of a hepatitis A outbreak among haemophilia patients in Korea, highlighting the need for HAV vaccination in this population.
Answers are grounded in this paper and cite their sources.
Prompts lot tracing in haemophilia HAV cases; leaves open vaccination policy changes pending confirmatory data.
To investigate the causal relationship of blood clotting factors and hepatitis A virus (HAV) infection in haemophilia patients during 1998-1999 in Korea, we performed a 1:3 matched case-control study and molecular detection of HAV from clotting factors and patients. The epidemiological investigation showed that one lot of clotting factor VIII was related epidemiologically to patients with hepatitis A with an odds ratio of 35.0, or 38.4 when adjusted for the interval between injections. We examined 17 sera collected from seven patients and 124 lots of blood clotting factors (factor VIII and factor IV) by HAV reverse transcriptase-polymerase chain reaction (RT-PCR). HAV RNA was detected in five clotting factors and six sera. The HAV sequence of one of the factor VIII samples was identical to the sequences found in three patients' sera. Findings from the laboratory and epidemiological studies suggested that the clotting factor was causally related to HAV infection in three haemophilia patients.
No takes yet. Share an insight, caveat, or question.
Jee et al. (2005) conducted a case-control in Haemophilia with acute hepatitis A (n=123). Clotting factor VIII lot no. 1950177 vs. Unexposed to this specific lot was evaluated on Acute hepatitis A infection (OR 35.0, 95% CI 11.3-108.9, p=<0.01). Exposure to clotting factor VIII lot no. 1950177 was associated with an outbreak of hepatitis A among haemophilia patients.
Synapse has enriched 10 related papers. Consider them for comparative context: